Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AIVFW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-MUC16 antibody 3A5-BMPEO-DM1
|
|||||
| Synonyms |
Anti-MUC16 antibody 3A5 BMPEO DM1
Click to Show/Hide
|
|||||
| Organization |
Genentech, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Prostate cancer [ICD11:2C82]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.6
|
|||||
| Antibody Name |
Anti-MUC16 antibody 3A5
|
Antibody Info | ||||
| Antigen Name |
Mucin-16 (MUC16)
|
Antigen Info | ||||
| Payload Name |
Maytansinoid DM1
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Anti-MUC16 antibody 3A5-BMPEO-DM1 linker
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.